Claravis Capsule, Liquid Filled
Product Images NDC 0555-1057

10 FDA label images from Teva Pharmaceuticals Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Claravis (NDC 0555-1057). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Image 1
An illustration showing the silhouette of a pregnant woman with a prohibition symbol overlaid, indicating a warning or contraindication related to pregnancy.*
FDA Label Image

Claravis (isotretinoin Capsules Usp) 40 mg, 3 Blister Packs Of 10 Capsules Each Carton, Part 2 Of 2 (Image 10)

Claravis (isotretinoin Capsules Usp) 40 mg, 3 Blister Packs Of 10 Capsules Each Carton, Part 2 Of 2 (Image 10)
Claravis 40 mg isotretinoin capsules USP carton, liquid-filled oral capsules. The package contains 3 prescription blister packs with 10 capsules each, totaling 30 capsules. Labeler is Teva Pharmaceuticals USA, Inc. The packaging includes prescription-only status and warnings about birth defects and pregnancy prevention.*
FDA Label Image

Image 2

Image 2
Chemical structure of isotretinoin, the active ingredient in Claravis capsules. The diagram depicts the molecular structure with a series of double bonds and a carboxyl group (COOH) at one end.*
FDA Label Image

Image 3

Image 3
Claravis 10 mg isotretinoin capsules USP packaging label for 3 prescription blister packs of 10 capsules each (30 capsules total). The label shows the brand and generic names, strength, dosage form as liquid-filled capsules, and dispensing instructions. It includes warnings such as "Contraindicated in Pregnancy" and storage conditions. The labeler is Teva Pharmaceuticals USA, Inc., North Wales, PA.*
FDA Label Image

Image 4

Image 4
Claras 10 mg isotretinoin capsules USP carton label for oral liquid-filled capsules. The packaging indicates a total of 3 prescription blister packs containing 10 capsules each, for a total of 30 capsules. It includes safety warnings about birth defects and instructions to protect from light. Manufactured by Teva Pharmaceuticals USA, Inc.*
FDA Label Image

Image 5

Image 5
Packaging label for Claravis 20 mg isotretinoin capsules USP, liquid-filled oral capsules by Teva Pharmaceuticals USA, Inc. The label indicates a 3 blister pack containing 10 capsules each, totaling 30 capsules. It includes warnings to protect from light and contraindications for pregnancy.*
FDA Label Image

Image 6

Image 6
Claravis 20 mg isotretinoin capsules USP packaging label for oral liquid-filled capsules. The label shows a carton containing 3 prescription blister packs with 10 capsules each (30 capsules total). The product is labeled with warnings including birth defects and instructions to protect from light. The labeler is Teva Pharmaceuticals USA, Inc.*
FDA Label Image

Image 7

Image 7
Claravis 30 mg isotretinoin capsules USP packaging label showing the product name, strength, dosage form as liquid-filled capsules, and prescription-only status. The label includes the quantity of 3 prescription blister packs of 10 capsules each, manufacturer Teva Pharmaceuticals USA, and storage instructions. A warning 'Contraindicated in Pregnancy' is present in red text.*
FDA Label Image

Image 8

Image 8
Packaging label for Claravis 30 mg isotretinoin capsules USP, oral liquid-filled capsules. The label indicates a package of 3 prescription blister packs, each containing 10 capsules (30 capsules total). The labeler is Teva Pharmaceuticals USA, Inc. The label includes warnings to protect from light and a birth defect caution symbol.*
FDA Label Image

Image 9

Image 9
Packaging label for Claravis 40 mg isotretinoin capsules USP by Teva Pharmaceuticals USA, Inc. The label indicates oral liquid-filled capsules with 40 mg strength, packaged as 3 prescription blister packs of 10 capsules each (30 capsules total). It includes pregnancy contraindication warnings, handling instructions to protect from light, and storage conditions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.